Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-01 | 2023-02-09 | 176854 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-12-22 | 2023-04-28 | 179188 |
TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-22 | 2023-02-09 | 179303 |
TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-02 | 2023-09-07 | 183419 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-06-08 | 2023-10-03 | 194100 |
TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-06-16 | 2023-07-05 | 195139 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-06-19 | 2023-07-06 | 195509 |
TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2023-06-19 | 2024-03-18 | 195649 |
TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2023-06-20 | 2024-03-18 | 195879 |
TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-04 | 2023-08-04 | 197169 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Actual shortage | 2023-10-05 | 2023-11-09 | 206407 |
TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2023-10-05 | 2024-01-25 | 206431 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-11-30 | 2024-01-19 | 211979 |
TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-01-11 | 2024-06-07 | 215751 |
TEVA-RISEDRONATE | 30MG | TABLET | Actual shortage | 2024-01-18 | 2024-01-19 | 216497 |
TEVA-CINACALCET | 30MG | TABLET | Actual shortage | 2024-04-11 | 2024-06-07 | 224907 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227480 |
ACT PIOGLITAZONE | 30MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227486 |
TEVA-VALSARTAN | 320MG | TABLET | Actual shortage | 2021-04-22 | 2021-04-22 | 137939 |
TEVA-TRAMADOL/ACETAMINOPHEN | 325MG 37.5MG | TABLET | Resolved | 2021-02-25 | 2021-06-03 | 134738 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |